BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30226554)

  • 1. Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines.
    Li X; Yin A; Zhang W; Zhao F; Lv J; Lv J; Sun J
    Int J Mol Med; 2018 Nov; 42(5):2923-2929. PubMed ID: 30226554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
    Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
    PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
    Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
    J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway.
    Yue G; Chen C; Bai L; Wang G; Huang Y; Wang Y; Cui H; Xiao Y
    Mol Med Rep; 2019 Nov; 20(5):4551-4557. PubMed ID: 31702026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
    Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
    Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA Z38 promotes cell proliferation and metastasis in human renal cell carcinoma.
    He X; Liu H; Guo F; Feng Y; Gao Y; Sun F; Song B; Lu H; Li Y
    Mol Med Rep; 2017 Oct; 16(4):5489-5494. PubMed ID: 28849012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
    Lin H; Zeng W; Lei Y; Chen D; Nie Z
    Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.
    Gao Y; Yan Y; Guo J; Zhang Q; Bi D; Wang F; Chang Z; Lu L; Yao X; Wei Q
    Oncol Rep; 2019 Sep; 42(3):1066-1074. PubMed ID: 31322246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
    Su Y; Zhou L; Yu Q; Lu J; Liu W
    Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma.
    Min X; Zhang X; Li Y; Cao X; Cheng H; Li Y; Li C; Kong Q; Mao Q; Peng P; Ni Y; Li J; Duan Y; Liu L; Ding Z
    Theranostics; 2020; 10(19):8573-8590. PubMed ID: 32754264
    [No Abstract]   [Full Text] [Related]  

  • 19. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.